Clinical features, genetics and potential therapeutic approaches for Birt–Hogg–Dubé syndrome

Bibliography

• Birt AR, Hogg GR, Dubé WJ. Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons. Arch Dermatol 1977;113:1674-7
   PubMed Web of Science ®Google Scholar
• Pinkus H, Coskey RJ, Burgess GA. Trichodiscoma: a benign tumor relating to haarscheibe (hair disc). J Invest Dermatol 1974;63:212
   PubMed Web of Science ®Google Scholar
• Hornstein OP, Knickenberg M. Perifollicular fibromatosis cutis with polyps of the colon – a cutaneo-intestinal syndrome sui generis. Arch Dermatol Res 1975;253:161-75
   PubMedGoogle Scholar
• Happle R. Hornstein-Birt-Hogg-Dubé syndrome: a renaming and reconsideration. Am J Med Genet A 2012;158A:1247-51
   Google Scholar
• Binet O, Robin J, Vicart M, et al. Fibromes perifolliculaires polypose colique familiale pneumothorax spontanes familiaux. Ann Dermatol Venereo 1986;113:928-30
   Google Scholar
• Chung JY, Ramos-Caro FA, Beers B, et al. Multiple lipomas, angiolipomas, and parathyroid adenomas in a patient with Birt-Hogg-Dube´ syndrome. Int J Dermatol 1996;35:365-7
   Google Scholar
• Toro JR, Glenn G, Duray P, et al. Birt-Hogg-Dubé syndrome: a novel marker of kidney neoplasia. Arch Dermatol 1999;135:1195-202
   PubMed Web of Science ®Google Scholar
• Roth JS, Rabinowitz AD, Benson M, et al. Bilateral renal cell carcinoma in the Birt-Hogg-Dubé syndrome. J Am Acad Dermatol 1993;29:1055-6
   PubMed Web of Science ®Google Scholar
• Schmidt LS, Nickerson ML, Warren MB, et al. Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dubé syndrome. Am J Hum Genet 2005;76:1023-33
   PubMed Web of Science ®Google Scholar
• Toro JR, Wei MH, Glenn GM, et al. BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports. J Med Genet 2008;45:321-31
   PubMed Web of Science ®Google Scholar
• Leter EM, Koopmans AK, Gille JJ, et al. Birt-Hogg-Dubé syndrome: clinical and genetic studies of 20 families. J Invest Dermatol 2008;128:45-9
   Google Scholar
• Kluger N, Giraud S, Coupier I, et al. Birt-Hogg-Dubé syndrome: clinical and genetic studies of 10 French families. Br J Dermatol 2010;162:527-37
   PubMed Web of Science ®Google Scholar
• Fibrofolliculoma and trichodiscoma. In: Ackerman AB, de Viragh PA, Chongchitnant N, editors. Neoplasms with follicular differentiation. Lea & Febiger; Philadelphia: 1993. p. 245
   Google Scholar
• Schulz T, Hartschuh W. Birt-Hogg-Dube´ Syndrome and Hornstein-Knickenberg syndrome are the same: different sectioning technique as the cause of different histology. J Cutan Pathol 1999;26:55-61
   PubMed Web of Science ®Google Scholar
• Weedon D. Skin pathology. 2d edition. Churchill Livingston; London: 2002. p. 871
   Google Scholar
• Tobino K, Gunji Y, Kurihara M, et al. Characteristics of pulmonary cysts in Birt-Hogg-Dubé syndrome: thin-section CT findings of the chest in 12 patients.Eur J Radiol. 2011;77:403-9
   Google Scholar
• Toro JR, Pautler SE, Stewart L, et al. Lung cysts, spontaneous pneumothorax, and genetic associations in 89 families with Birt-Hogg-Dubé syndrome. Am J Respir Crit Care Med 2007;175:1044-53
   PubMed Web of Science ®Google Scholar
• Gunji Y, Akiyoshi T, Sato T, et al. Mutations of the Birt Hogg Dube´ gene in patients with multiple lung cysts and recurrent pneumothorax. J Med Genet 2007;44:588-93
   Web of Science ®Google Scholar
• Painter JN, Tapanainen H, Somer M, et al. A 4-bp deletion in the Birt-Hogg-Dube´ gene (FLCN) causes dominantly inherited spontaneous pneumothorax. Am J Hum Genet 2005;76:522-7
   Web of Science ®Google Scholar
• Graham RB, Nolasco M, Peterlin B, et al. Nonsense mutations in folliculin presenting as isolated familial spontaneous pneumothorax in adults. Am J Respir Crit Care Med 2005;172:39-44
   Google Scholar
• Ren HZ, Zhu CC, Yang C, et al. Mutation analysis of the FLCN gene in Chinese patients with sporadic and familial isolated primary spontaneous pneumothorax. Clin Genet 2008;74:178-83
   PubMed Web of Science ®Google Scholar
• Ayo DS, Aughenbaugh GL, Yi ES, et al. Cystic lung disease in Birt-Hogg-Dube´syndrome. Chest 2007;132:679-84
   Google Scholar
• Zbar B, Alvord WG, Glenn G, et al. Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dubé syndrome.Cancer Epidemiol Biomarkers Prev. 2002;11:393-400
   Google Scholar
• Bessis D, Giraud S, Richard S. A novel familial germline mutation in the initiator codon of the BHD gene in a patient with Birt-Hogg-Dube´ syndrome. Br J Dermatol 2006;155:1067-9
   Web of Science ®Google Scholar
• Houweling AC, Gijezen LM, Jonker MA, et al. Renal cancer and pneumothorax risk in Birt-Hogg-Dubé syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD families. Br J Cancer 2011;105:1912-19
   PubMed Web of Science ®Google Scholar
• Pavlovich CP, McClellan MW, Eyler RA, et al. Renal tumors in the Birt-Hogg-Dube´syndrome. Am J Surg Pathol 2002;26:1542-52
   PubMed Web of Science ®Google Scholar
• Pavlovich CP, Grubb RLIII, Hurley K, et al. Evaluation and management of renal tumors in the Birt-Hogg-Dubé syndrome. J Urol 2005;173:1482-6
   PubMed Web of Science ®Google Scholar
• Rongioletti F, Hazini R, Gianotti G, et al. Fibrofolliculomas, trichodiscomas and achrocordons (Birt-Hogg-Dube´) associated with intestinal polyposis. Clin Exp Dermatol 1989;14:72-4
   Google Scholar
• Le Guyadec T, Dufau JP, Poulain JF, et al. Multiple trichodiscomas associated with colonic polyposis. Ann Dermatol Venereol 1998;125:717-19
   Google Scholar
• Nahorski MS, Lim DH, Martin L, et al. Investigation of the Birt-Hogg-Dube´ tumour suppressor gene (FLCN) in familial and sporadic colorectal cancer. J Med Genet 2010;47:385-90
   Google Scholar
• Khoo SK, Giraud S, Kahnoski K, et al. Clinical and genetic studies of Birt-Hogg-Dube´ syndrome. J Med Genet 2002;39:906-12
   PubMed Web of Science ®Google Scholar
• Liu V, Kwan T, Page EH. Parotid oncocytoma in the Birt-Hogg-Dubé syndrome. J Am Acad Dermatol 2000;43:1120-2
   Google Scholar
• Maffé A, Toschi B, Circo G, et al. Constitutional FLCN mutations in patients with suspected Birt-Hogg-Dubé syndrome ascertained for non-cutaneous manifestations. Clin Genet 2011;79:345-54
   Google Scholar
• Pradella LM, Lang M, Kurelac I, et al. Where Birt-Hogg-Dubé meets Cowden syndrome: mirrored genetic defects in two cases of syndromic oncocytic tumours. Eur J Hum Genet 2013;21(10):1169-72
   Google Scholar
• Weirich G, Glenn G, Junker K, et al. Familial renal oncocytoma: clinicopathological study of 5 families. J Urol 1998;160:335-40
   PubMed Web of Science ®Google Scholar
• Schmidt LS, Warren MB, Nickerson ML, et al. Birt-Hogg-Dubé syndrome, a genodermatosis associated with spontaneous pneumothorax and kidney neoplasia, maps to chromosome 17p11.2. Am J Hum Genet 2001;69:876-82
   PubMed Web of Science ®Google Scholar
• Khoo SK, Bradley M, Wong FK, et al. Birt-Hogg-Dubé syndrome: mapping of a novel hereditary neoplasia gene to chromosome 17p12-q11.2.Oncogene. 2001;20:5239-42
   Google Scholar
• Nickerson ML, Warren MB, Toro JR, et al. Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome. Cancer Cell 2002;2:157-64
   PubMed Web of Science ®Google Scholar
• Lim DH, Rehal PK, Nahorski MS, et al. A new locus-specific database (LSDB) for mutations in the folliculin (FLCN) gene. Hum Mutat 2010;31:E1043-51
   Web of Science ®Google Scholar
• European Birt-Hogg-Dube´Consortium LOVD Gene Homepage for FLCN. Available from: https://grenada.lumc.nl/LOVD2/shared1/home.php?select_db=FLCN [Last visited 12 October 2014]
   Google Scholar
• Kunogi M, Kurihara M, Ikegami TS, et al. Clinical and genetic spectrum of Birt-Hogg-Dube´ syndrome patients in whom pneumothorax and/or multiple lung cysts are the presenting feature. J Med Genet 2010;47:281-7
   Web of Science ®Google Scholar
• Benhammou JN, Vocke CD, Santani A, et al. Identification of intragenic deletions and duplication in the FLCN gene in Birt-Hogg-Dubé syndrome. Genes Chromosomes Cancer 2011;50:466-77
   Google Scholar
• Nahorski MS, Reiman A, Lim DH, et al. Birt Hogg-Dubé syndrome-associated FLCN mutations disrupt protein stability. Hum Mutat 2011;32:921-9
   Google Scholar
• Gad S, Lefèvre SH, Khoo SK, et al. Mutations in BHD and TP53 genes, but not in HNF1beta gene, in a large series of sporadic chromophobe renal cell carcinoma. Br J Cancer 2007;96:336-40
   PubMed Web of Science ®Google Scholar
• Khoo SK, Kahnoski K, Sugimura J, et al. Inactivation of BHD in sporadic renal tumors. Cancer Res 2003;63:4583-7
   PubMed Web of Science ®Google Scholar
• da Silva NF, Gentle D, Hesson LB, et al. Analysis of the Birt-Hogg-Dubé (BHD) tumour suppressor gene in sporadic renal cell carcinoma and colorectal cancer.J Med Genet. 2003;40:820-4
   Google Scholar
• Nagy A, Zoubakov D, Stupar Z, et al. Lack of mutation of the folliculin gene in sporadic chromophobe renal cell carcinoma and renal oncocytoma. Int J Cancer 2004;109:472-5
   PubMed Web of Science ®Google Scholar
• Davis CF, Ricketts CJ, Wang M, et al. The Cancer Genome Atlas Research Network. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell 2014;26:319-30
   PubMed Web of Science ®Google Scholar
• Vocke CD, Yang Y, Pavlovich CP, et al. High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dubé-associated renal tumors. J Natl Cancer Inst 2005;97:931-5
   Google Scholar
• Yang Y, Padilla-Nash HM, Vira MA, et al. The UOK. 257 cell line: a novel model for studies of the human Birt-Hogg-Dubé gene pathway. Cancer Genet Cytogenet 2008;180:100-9
   PubMedGoogle Scholar
• Hong SB, Oh H, Valera VA, et al. Tumor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules in TGF-beta signaling. Mol Cancer 2010;9:160
   Google Scholar
• Hudon V, Sabourin S, Dydensborg AB, et al. Renal tumour suppressor function of the Birt-Hogg-Dubé syndrome gene product folliculin. J Med Genet 2010;47:182-9
   PubMed Web of Science ®Google Scholar
• van Steensel MA, Verstraeten VL, Frank J, et al. Novel mutations in the BHD gene and absence of loss of heterozygosity in fibrofolliculomas of Birt-Hogg-Dubé patients. J Invest Dermatol 2007;127:588-93
   PubMedGoogle Scholar
• Koga S, Furuya M, Takahashi Y, et al. Lung cysts in Birt-Hogg-Dubé syndrome: histopathological characteristics and aberrant sequence repeats. Pathol Int 2009;59:720-8
   Google Scholar
• Baba M, Hong SB, Sharma N, et al. Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling. Proc Natl Acad Sci USA 2006;103:15552-7
   PubMed Web of Science ®Google Scholar
• Shaw RJ. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth. Acta Physiol (Oxf) 2009;196:65-80
   PubMed Web of Science ®Google Scholar
• Wang L, Kobayashi T, Piao X, et al. Serine 62 is a phosphorylation site in folliculin, the Birt-Hogg-Dubé gene product. FEBS Lett 2010;584:39-43
   PubMedGoogle Scholar
• Piao X, Kobayashi T, Wang L, et al. Regulation of folliculin (the BHD gene product) phosphorylation by Tsc2-mTOR pathway. Biochem Biophys Res Commun 2009;389:16-21
   Google Scholar
• Takagi Y, Kobayashi T, Shiono M, et al. Interaction of folliculin (Birt-Hogg-Dubé gene product) with a novel Fnip1-like (FnipL/Fnip2) protein. Oncogene 2008;27:5339-47
   Google Scholar
• Lim TH, Fujikane R, Sano S, et al. Activation of AMP-activated protein kinase by MAPO1 and FLCN induces apoptosis triggered by alkylated base mismatch in DNA. DNA Repair (Amst) 2012;11:259-66
   Google Scholar
• Hasumi H, Baba M, Hong SB, et al. Identification and characterization of a novel folliculin-interacting protein FNIP2. Gene 2008;415(1-2):60-7
   PubMed Web of Science ®Google Scholar
• Baba M, Keller JR, Sun HW, et al. The Folliculin-FNIP1 pathway deleted in human Birt-Hogg-Dube syndrome is required for mouse B cell development. Blood 2012;120:1254-61
   PubMedGoogle Scholar
• Park H, Staehling K, Tsang M, et al. Disruption of Fnip1 reveals a metabolic checkpoint controlling B lymphocyte development. Immunity 2012;36:769-81
   PubMed Web of Science ®Google Scholar
• Baba M, Furihata M, Hong SB, et al. Kidney-targeted Birt-Hogg-Dube´ gene inactivation in a mouse model: erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys. J Natl Cancer Inst 2008;100:140-54
   PubMedGoogle Scholar
• Chen J, Futami K, Petillo D, et al. Deficiency of FLCN in mouse kidney led to development of polycystic kidneys and renal neoplasia. PLoS One 2008;3:e3581
   Web of Science ®Google Scholar
• Hasumi Y, Baba M, Ajima R, et al. Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2. Proc Natl Acad Sci USA 2009;106:18722-7
   PubMed Web of Science ®Google Scholar
• Hartman TR, Nicolas E, Klein-Szanto A, et al. The role of the Birt-Hogg-Dubé protein in mTOR activation and renal tumorigenesis. Oncogene 2009;28:1594-604
   PubMed Web of Science ®Google Scholar
• van Slegtenhorst M, Khabibullin D, Hartman TR, et al. The Birt-Hogg-Dube´ and tuberous sclerosis complex homologs have opposing roles in amino acid homeostasis in Schizosaccharomyces pombe. J Biol Chem 2007;282:24583-90
   PubMedGoogle Scholar
• Cash TP, Gruber JJ, Hartman TR, et al. Loss of the Birt-Hogg-Dubé tumor suppressor results in apoptotic resistance due to aberrant TGFβ-mediated transcription. Oncogene 2011;30:2534-46
   PubMed Web of Science ®Google Scholar
• Klomp JA, Petillo D, Niemi NM, et al. Birt-Hogg-Dubé renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression. BMC Med Genomics 2010;3:59
   PubMed Web of Science ®Google Scholar
• Hasumi H, Baba M, Hasumi Y, et al. Regulation of mitochondrial oxidative metabolism by tumor suppressor FLCN. J Natl Cancer Inst 2012;104:1750-64
   Google Scholar
• Hasumi Y, Baba M, Hasumi H, et al. Folliculin (Flcn) inactivation leads to murine cardiac hypertrophy through mTORC1 deregulation. Hum Mol Genet 2014;23:5706-19
   Google Scholar
• Hong SB, Oh H, Valera VA, et al. Inactivation of the FLCN tumor suppressor gene induces TFE3 transcriptional activity by increasing its nuclear localization. PLoS One 2010;5:e15793
   PubMed Web of Science ®Google Scholar
• Petit CS, Roczniak-Ferguson A, Ferguson SM. Recruitment of folliculin to lysosomes supports the amino acid-dependent activation of Rag GTPases. J Cell Biol 2013;202:1107-22
   PubMed Web of Science ®Google Scholar
• Roczniak-Ferguson A, Petit CS, Froehlich F, et al. The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis. Sci Signal 2012;5:ra42
   PubMed Web of Science ®Google Scholar
• Betschinger J, Nichols J, Dietmann S, et al. Exit from pluripotency is gated by intracellular redistribution of the bHLH transcription factor Tfe3. Cell 2013;153:335-47
   PubMed Web of Science ®Google Scholar
• Bar-Peled L, Sabatini DM. Regulation of mTORC1 by amino acids. Trends Cell Biol 2014;24:400-6
   PubMed Web of Science ®Google Scholar
• Tsun ZY, Bar-Peled L, Chantranupong L, et al. The folliculin tumor suppressor is a GAP for the RagC/D GTPases that signal amino acid levels to mTORC1. Mol Cell 2013;52:495-505
   PubMed Web of Science ®Google Scholar
• Nookala RK, Langemeyer L, Pacitto A, et al. Crystal structure of folliculin reveals a hidDENN function in genetically inherited renal cancer. Open Biol 2010;2:120071
   Google Scholar
• Medvetz DA, Khabibullin D, Hariharan V, et al. Folliculin, the product of the Birt-Hogg-Dube´ tumor suppressor gene, interacts with the adherens junction protein p0071 to regulate cell-cell adhesion. PLoS One 2012;7:e47842
   PubMedGoogle Scholar
• Nahorski MS, Seabra L, Straatman-Iwanowska A, et al. Folliculin interacts with p0071 (plakophilin-4) and deficiency is associated with disordered RhoA signalling, epithelial polarization and cytokinesis. Hum Mol Genet 2012;21:5268-79
   Google Scholar
• Khabibullin D, Medvetz DA, Pinilla M, et al. Folliculin regulates cell-cell adhesion, AMPK, and mTORC1 in a cell-type-specific manner in lung-derived cells. Physiol Rep 2014;2:(8): pii:e12107
   Google Scholar
• Goncharova EA, Goncharov DA, James ML, et al. Folliculin controls lung alveolar enlargement and epithelial cell survival through E-cadherin, LKB1, and AMPK. Cell Rep 2014;7:412-23
   Google Scholar
• Luijten MN, Basten SG, Claessens T, et al. Birt-Hogg-Dube´ syndrome is a novel ciliopathy.Hum Mol Genet. 2013;22:4383-97
   Google Scholar
• Possik E, Jalali Z, Nouët Y, et al. Folliculin regulates ampk-dependent autophagy and metabolic stress survival. PLoS Genet 2014;10:e1004273
   PubMed Web of Science ®Google Scholar
• Dunlop EA, Seifan S, Claessens T, et al. FLCN, a novel autophagy component, interacts with GABARAP and is regulated by ULK1 phosphorylation. Autophagy 2014;10(10):1749-60
   PubMed Web of Science ®Google Scholar
• Farrant PB, Emerson R. Letter: hyfrecation and curettage as a treatment for fibrofolliculomas in Birt–Hogg–Dube syndrome. Dermatol Surg 2007;33:1287-8
   PubMedGoogle Scholar
• Gambichler T, Wolter M, Altmeyer P, et al. Treatment of Birt–Hogg–Dube´ syndrome with erbium:YAG laser. J Am Acad Dermatol 2000;43(5 Pt 1):856-8
   Web of Science ®Google Scholar
• Vernooij M, Claessens T, Luijten M, et al. Birt-Hogg-Dubé syndrome and the skin. Fam Cancer 2013;12:381-5
   Google Scholar
• Gupta N, Seyama K, McCormack FX. Pulmonary manifestations of Birt-Hogg-Dube´syndrome. Fam Cancer 2013;12:387-96
   Web of Science ®Google Scholar
• Menko FH, van Steensel MA, Giraud S, et al. European BHD Consortium. Birt-Hogg-Dubé syndrome: diagnosis and management. Lancet Oncol 2009;10:1199-206
   PubMed Web of Science ®Google Scholar
• Medical Guidelines of the World Recreational Scuba training Council. Available from: http://wrstc.com/downloads/10-Medical Guidelines.pdf [Last visited 11/4/2014]
   Google Scholar
• Stamatakis L, Metwalli AR, Middelton LA, et al. Diagnosis and management of BHD-associated kidney cancer. Fam Cancer 2013;12:397-402
   PubMed Web of Science ®Google Scholar
• Nakamura M, Yao M, Sano F, et al. [A case of metastatic renal cell carcinoma associated with Birt-Hogg-Dubé syndrome treated with molecular-targeting agents]. Hinyokika Kiyo 2013;59:503-6
   PubMedGoogle Scholar
• Claessens T, Weppler SA, van Geel M, et al. Neuroendocrine carcinoma in a patient with Birt-Hogg-Dubé syndrome. Nat Rev Urol 2010;7:583-7
   PubMedGoogle Scholar
• Gijezen LM, Vernooij M, Martens H, et al. Topical rapamycin as a treatment for fibrofolliculomas in Birt-Hogg-Dubé syndrome: a double-blind placebo-controlled randomized split-face trial. PLoS One 2014;9:e99071
   Web of Science ®Google Scholar
• Preston RS, Philp A, Claessens T, et al. Absence of the Birt-Hogg-Dubé gene product is associated with increased hypoxia-inducible factor transcriptional activity and a loss of metabolic flexibility. Oncogene 2011;30:1159-73
   PubMedGoogle Scholar
• Yan M, Gingras MC, Dunlop EA, et al. The tumor suppressor folliculin regulates AMPK-dependent metabolic transformation. J Clin Invest 2014;124:2640-50
   PubMed Web of Science ®Google Scholar
• Lu X, Wei W, Fenton J, et al. Therapeutic targeting the loss of the Birt-Hogg-Dube´ suppressor gene. Mol Cancer Ther 2011;10:80-9
   Google Scholar
• Lu X, Boora U, Seabra L, et al. Knockdown of Slingshot 2 (SSH2) serine phosphatase induces Caspase3 activation in human carcinoma cell lines with the loss of the Birt-Hogg-Dubé tumour suppressor gene (FLCN). Oncogene 2014;33:956-65
   Google Scholar
• Knudson AGJr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971;68:820-3
   PubMed Web of Science ®Google Scholar
• Schmidt LS. Birt-Hogg-Dubé syndrome: from gene discovery to molecularly targeted therapies.Fam Cancer. 2013;12:357-64
   Google Scholar